Active Surveillance Prostate Cancer Video Chat, March 11th, 2026
AnCan is grateful to the following sponsors for making this recording possible: Novartis, Telix, Blue Earth Diagnostics, and Foundation Medicine.
Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us.
You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/. Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/.
Chat Log:
Michael 8:17 PM
I’m good, I have to drop off at five for work. Just got interrupted once so I may drop off before 5.
Eric- Atlanta 8:20 PM
TP with MRI Fusion list: https://www.researchgate.net/figure/List-of-some-current-platforms-for-MRI-ultrasound-fusion-biopsy_tbl3_379682364
Eric- Atlanta 8:23 PM
ExactVU finder: https://www.exactimaging.com/physician-finder
AnCan – Rick 8:30 PM
29 Neither DRE nor bicycle riding appreciably alters the PSA,30, 31 and most controlled studies evaluating ejaculation suggest it either does not significantly impact or modestly increases (~10%) PSA.32
AnCan – Rick 8:32 PM
(30) Crawford ED, Schutz MJ, Clejan S et al: The effect of digital rectal examination on prostate-specific antigen levels. JAMA 1992; 267: 2227 (31) Jiandani D, Randhawa A, Brown RE et al: The effect of bicycling on psa levels: A systematic review and meta-analysis. Prostate Cancer Prostatic Dis 2015; 18: 208 (32) Tarhan F, Demir K, Orcun A and Madenci OC: Effect of ejaculation on serum prostate-specific antigen concentration. Int Braz J Urol 2016; 42: 472
AnCan – Dan 8:34 PM
https://www.auanet.org/guidelines-and-quality/guidelines/oncology-guidelines/prostate-cancer
Eric- Atlanta 8:35 PM
Current NCCN Guidelines:https://www.nccn.org/patients/guidelines/content/PDF/prostate-early-patient.pdf
AnCan – Dan 8:40 PM
https://www.cancer.org/cancer/latest-news/can-getting-a-biopsy-make-cancer-spread.html
AnCan – Rick 8:41 PM
Cancer PEP https://cancerpep.com/
AnCan – Dan 8:43 PM
https://pmc.ncbi.nlm.nih.gov/articles/PMC10814235/
Eric- Atlanta 8:59 PM
Re NCCN: I could not find any NCCN preparation procedures for PSA test on their link from above.
AnCan – Rick 9:03 PM
the patient-centric guidelines that Eric posted are ‘dumbed down’ for our consumption. The actual guidelines are what dan gifford provided.
AnCan – Rick 9:13 PM
Should also point out that what Eric posted are NCCN. What we’re speaking about are the AUA Guidelines.
Dan Pertschuk-San Diego 9:23 PM
It’s said that we all live two lives and the second life begins when we realize we only have one.
Eric- Atlanta 9:33 PM
“Who is Eligible for PCPEP PC-PEP is being offered as part of a research study to men who have had a prostate cancer diagnosis and meet the following criteria: Are safe to exercise and do strength training Have access to email and internet daily Are able to watch videos and willing to follow the program for 6 months Have a life expectancy of 2 years or more Willing to take 4 on-line surveys over two years as part of the trial”
Marty Keough Auburn NY 9:36 PM
Sorry I could not get my camera to show me or audio to speak to you! Thanks for what You All Do! Marty Keough
Active Surveillance Prostate Cancer Video Chat, February 25th, 2026
AnCan is grateful to the following sponsors for making this recording possible: Bayer, Novartis, Johnson and Johnson, Myriad Genetics, Telix, and Blue Earth Diagnostics.
Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us.
You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/. Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/.
Chat Log:
AnCan – Dan 8:19 PM
Matthew Cooperberg – ucfhealth.org/providers/matthew-cooperberg
AnCan – Dan 8:20 PM
Also try urology.ucsf.edu/people/cooperberg
Andy, Boca Raton, FL 8:24 PM
Ismail Baris Turkbey, M.D., F.S.A.R. Senior Clinician NCI/CCR/MIB National Institutes of Health Building 10, Room B3B85 Office Phone: 240-760-6112 turkbeyi@mail.nih.gov
Eric- Atlanta 8:31 PM
2nd Opinions for Biopsies -Jonathan Epstein, MD Contact: jepstein@imppllc.com https://advanceduropathology.com -Ming Zhou, MD, PHD Now at Mount Sinai Health System in New York City. If you have questions for him, please contact him directly at Email: Ming.zhou@mountsinai.org -John Hopkins Pathology https://pathology.jhu.edu/patient-care/second-opinions Biopsy Videos/Links topics: Master pathologist Zhou continues his primer on prostate biopsies https://howardwolinsky.substack.com/p/master-pathologist-zhou-continues Second Opinion Diagnosis in Prostate Pathology Grand Rounds in Urology https://www.youtube.com/watch?v=rTjOED_da1I Should You Get a Second Opinion on Gleason 6 Pathology Slides? Expert Laurence Klotz, MD https://www.youtube.com/watch?v=J9DE6xhKQ_4
BJ 8:38 PM
yes I will talk next week when it is not recorded
Pradeep Grama 8:38 PM
I get emails from AnCan
Eric- Atlanta 8:45 PM
MRI and Contrast(Gadolinium) use/issue 2025: https://www.sciencedirect.com/science/article/pii/S0730725X25000670?via%3Dihub No contrast MRI 9/25 Medscape: https://www.medscape.com/viewarticle/contrast-free-mri-optimal-test-pc-2025a1000nv9?ecd=WNL_trdalrt_pos1_250911_etid7712121&uac=302861BR&impID=7712121&fbclid=IwZnRzaAMwgi9leHRuA2FlbQIxMQABHhYYi9h3-7fJxsrc7c1tUF_oCJ6ZEVmMQJydgUnoePebgInLLQEfiflUJZzA_aem_MZIwUlQ5jszDg0e85x3AaQ
Eric- Atlanta 8:49 PM
Micro Ultrasound physician finder: https://www.exactimaging.com/physician-finder Micro Ultrasound vs MRI in guided biopsies OPTIMUM Trial Results(04/2025): https://www.vumedi.com/video/microultrasound-vs-mri-guided-biopsy-for-prostate-cancer-diagnosis-the-optimum-trial-results/?token=3bdedd05-0b76-4ec4-a1c9-064cd0806a8f&link_data=eyJiZXRfbWFpbF9pdGVtX2lkIjozODE1MDM5MDMsImJldF9tYWlsX2FjdGlvbiI6ImJjIn0%3A1u8F17%3AIbndn9N2vzQ0eVXcd_RdjDyNPHn0JrOEullWh-uonuY
Eric- Atlanta 8:58 PM
2nd Opinions for MRIs Botimage AI for MRIs: https://botimageai.com/prostatid/ ~$250, can also be used for biopsy targeting guidance NIH 2nd Opinion MRI (no fees): Choyke, Peter (NIH/NCI) Radiologist pchoyke@mail.nih.gov Second opinion of MRI from Johns Hopkins Images and Reports for Providers | Johns Hopkins Radiology (hopkinsmedicine.org) Email: eradiologycenter@jhmi.edu Phone: 443-287-7378 Fax: 443-769-1210 -Accolade Radiology NY, PA https://accoladeradiology.com/mritap.html Radiology Check (Switzerland) https://radiologycheck.com/en
AnCan – Dan 9:08 PM
aspatients.org/meeting/transperineal-vs-transrectal-prostate-biopsy/
Eric- Atlanta 9:18 PM
Prostate Biopsy: The Beginning of the End? with Dr. Mark Emberton: https://aspatients.org/event/mri-a-replacement-for-prostate-biopsy/
Active Surveillance Prostate Cancer Video Chat, February 11th, 2026
AnCan is grateful to the following sponsors for making this recording possible: Bayer, Novartis, Johnson and Johnson, Myriad Genetics, Telix, and Blue Earth Diagnostics.
Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us.
You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/. Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/.
Chat Log:
Ray E 8:25 PM
i know but if I just cut in I think others will to but if you prefer I will cut in
AnCan – Rick 8:39 PM
Dr. Sanoj Punnen https://sylvester-doctors.umiamihealth.org/provider/sanoj-punnen/525775
Hugh -Houston 8:48 PM
2nd Opinions for Biopsies: -Jonathan Epstein, MD https://advanceduropathology.com -Ming Zhou, MD, PHD Now at Mount Sinai Health System in New York City. If you have questions for him, please contact him directly at Email: Ming.zhou@mountsinai.org) -John Hopkins Pathology https://pathology.jhu.edu/patient-care/second-opinions
AnCan – Rick 8:49 PM
Dr. Michael Liss https://providers.ucsd.edu/details/1477733012/urology-cancer
Hi-Risk/Recurrent/Advanced PrCa Video Chat, 1/27/26
AnCan is closing out its Annual Fundraising Campaign. If you haven’t donated yet, consider the priceless value we bring . Please donate – especially if you watch our recordings and are not on our Mailchimp list. https://ancan.org/donate/
AnCan thanks the following sponsors for making this recording possible: Novartis, Johnson and Johnson, Telix, Blue Earth Diagnostics and Foundation Medicine.
Views expressed in this Recording are solely the opinion of AnCan Foundation, our Moderators and Participants.
AnCan does not accept sponsored promotion. Any drugs, protocols or devices discussed are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
All AnCan’s groups are free and drop-in … join us in person sometime! You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/ Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/
Join our other free and drop in groups:
Men (Only) Speaking Freely…1st & 3rd Thursdays @ 8.00 pm Eastern https://ancan.org/men-speaking-freely/
Veterans Healthcare Navigation… 1st & 3rd Tuesdays @ 8.00 pm Eastern Schmier Room https://ancan.org/veterans/
Veterans Speaking freely… 4th Tuesday @ @ 8.00 pm Eastern Schmier Room
HEADS-UP: another marathon session!!
Editor’s Pick: Disruptor attends solely to advocate for Dr. Kwon… and makes AnCan’s case with his own inappropriate overtreatment.
Topics Discussed
Potentially de novo metastatic Gent prefers faith to treatment; … and this de novo Mx man has fared well on doublet and radiotherapy RT; he’s more interested in chastising AnCan over Kwon than his own overtreatment; radiation proctitis discussion; kidneys backwashed from possible radiation damage; Clomid slow to restore T… give it time Dr. Jack; considering immunotherapy well before its time; raises the question – does TMB differ between tissue and blood samples?; v. low testosterone may not be related to previous PrCa treatment; new GU MO needed in Central Florida; PSMA is negative but started on Lupron; why shlepp to MDA – what’s wrong with Chicago?; back- end Newbie needs a GU med onc rather than uro; Kwon proselytizer won’t give up; Canadian placed on doublet per AnCan navigation is feeling good and grateful
Chat
Jon McPhee Toronto sent: 4:13 PM
Toronto is in Canada
Dan – Schenectady, NY sent: 4:41 PM
Thank you Bob
AnCan – Rick sent: 4:55 PM
Telephone # for tech assistance: 877 582 7011
Frank Ciambra sent: 5:25 PM
got to go ,see guys net week everyone have great weekend
Bruce Schrimpf sent: 5:38 PM
Got to go. Best to all of you! BDS
Lee Baylin sent: 5:45 PM
Good night.
AnCan – Rick sent: 5:45 PM
my DEXA showed -2.0 in spine and forearm last week. Doc just wants me to supplement with calcium and D.
oh… and resistance exercise!!
Steve Roux, North Michigan sent: 5:46 PM
I’m doing the same +K2
I resist exercise daily.😆
Peter M sent: 5:57 PM
good night gents!
Steve Roux, North Michigan sent: 5:58 PM
Great Meeting gang. I gotta run . Good night all.
Jim Marshall, Veteran, Alexandria, VA sent: 6:05 PM
Hey, 3 1/2 years on a Treatment Holiday and all is good. Jim
Julian – Houston sent: 6:15 PM
Thanks All – I will contact Dr E!
Thomas Matica sent: 6:15 PM
Good night. Thanks to everyone. Peace. Thomas.
Ron S Regina SK Canada sent: 6:21 PM
Thanks all. Gotta go.
Richard B, Silver Spring, MD sent: 6:27 PM
Goodnight gentlemen, I appreciate the feedback tonight. Very helpful
Jon McPhee Toronto sent: 6:29 PM
Nite all.
Bob Schwartz U.S.N. Venice, FL. sent: 6:32 PM
Good mtg., see you next week.
Jim Marshall, Veteran, Alexandria, VA sent: 6:58 PM
Active Surveillance Prostate Cancer Video Chat, January 28th, 2026
AnCan is grateful to the following sponsors for making this recording possible: Bayer, Novartis, Johnson and Johnson, Myriad Genetics, Telix, and Blue Earth Diagnostics.
Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us.
You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/. Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/.
Chat Log:
Eric- Atlanta 8:49 PM
2nd Opinions for Biopsies -Jonathan Epstein, MD Contact: jepstein@imppllc.com https://advanceduropathology.com -Ming Zhou, MD, PHD Now at Mount Sinai Health System in New York City. If you have questions for him, please contact him directly at Email: Ming.zhou@mountsinai.org -John Hopkins Pathology https://pathology.jhu.edu/patient-care/second-opinions
AnCan – Rick 8:50 PM
Recent article on finasteride/dutasteride and disease progression https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2822868?guestAccessKey=51fc10c5-3b12-4e00-903b-b8611dfbe9a5&utm_source=silverchair&utm_campaign=jama_network&utm_content=onc_weekly_highlights&utm_medium=email&adv=000002836268&mc_cid=c06ec53f6d&mc_eid=838454d636
Eric- Atlanta 9:18 PM
Latest April 2025 NCCN Guidelines for Early PCa: https://www.nccn.org/patients/guidelines/content/PDF/prostate-early-patient.pdf
AnCan – Rick 9:19 PM
Tx Dr. Dan – I recall there was something out there. Thanks
AnCan – Rick 9:22 PM
Early stage Guidelines https://www.nccn.org/patients/guidelines/content/PDF/prostate-early-patient.pdf
Hector 9:44 PM
This is now at the hypothetical level, no conclusive evidence yet: NPR: Could mRNA vaccines help fight cancer? https://www.npr.org/2022/06/05/1103178829/could-mrna-vaccines-help-fight-cancer
